The Global Incubator Programme is an acceleration programme for innovative SMEs to grow and scale through exploring the potential of global markets. Are you ready to scale your business globally? To successfully scale your business globally you need to understand the requirements of different markets and build the necessary partnerships, collaborations, and...
NHS England has announced the third round of the NHS Cancer Programme Innovation Open Call
The NHS Cancer Programme invites innovations or new approaches that will detect cancers earlier and increase the proportion diagnosed at stage one or two. The competition aims to fast-track high quality, proven, late-stage innovations into front-line settings, as well as address implementation evidence gaps. Innovations will be 100% funded up to...
New funding programme launched to accelerate healthcare innovation in the East Midlands
Medilink Midlands and Health Innovation East Midlands (formerly East Midlands Academic Health Science Network - EMAHSN) have joined forces to launch a new programme designed to support and accelerate healthcare innovation in the region. The Health Innovation Fund offers support of between £5,000 and £10,000 to enable East Midlands-based SMEs or...
Place Based Impact Acceleration Account: East Midlands Emerging Research Growth for MedTech Enterprise (EMERGE)
What is a Placed Based Impact Acceleration Account (PBIAA)? In October 2023, the Engineering and Physical Sciences Research Council (EPSRC) released a call for round two of their PBIAA scheme, which is intended to enhance the capabilities of research and innovation clusters across the UK to drive economic and societal...
Nine coveted awards up for grabs at Medilink Midlands Business Awards 2024
Applications are now open for Medilink Midlands’ Business Awards which will once again celebrate the work and achievements of life sciences companies across the Midlands. With nine categories from Start-Up to Outstanding Achievement, the 2024 awards are set to be bigger and better than ever and will highlight some of...
Influx of promotions and new starters at Cellomatics signals next successful phase for award winning business
Specialist preclinical contract research organisation (CRO) Cellomatics Biosciences has heralded the start of its next successful phase with four promotions and eight new arrivals. Dr Shailendra Singh, CEO of Cellomatics Biosciences, comments: “Capitalising on our existing strengths and internal team expertise, we intend to further consolidate our position as a...
Medilink Midlands CEO Melanie Davidson gives expert insight on the Rosalind Franklin Laboratory
The sale of a vast COVID-19 testing lab in the UK is an opportunity to develop the start-up ecosystem in the Midlands region. But what form of repurposing would serve the region best: a general life sciences hub, or a specialist research and innovation centre? Both options have been floated...
Long term cost savings and quality outcomes for the NHS
New findings from Spirit Health’s prescribing change programmes Research released - demonstrating how a prescribing change program can deliver long-term cost efficiencies and improve patient treatment Greater Manchester achieved a significant 29.6% cost reduction in self-monitoring of blood glucose units over the 6 years Outperforming the average cost reduction in...
Upperton announces expansion into sterile drug manufacturing with new £5million GMP facility
Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has announced a £5million investment to expand operations into small-scale sterile fill-finish. After completing the build and qualification of a new 50,000sqft GMP facility during 2023, the UK-based CDMO announces further expansion at its Trent Gateway site to...
Implementation of the Future Regulations – A view on the Roadmap
In this article Medilink Midlands' Head of Connectivity Chris Dyke shares his thoughts on the Implementation of the Future Regulations. In viewing this new document (9 Jan 2024) the first part of Implementation of the Future Regulations provides additional clarity to what has been previously announced i.e. ‘Transitional Arrangements’ and...